SLC35A2 and colorectal carcinoma: In the present study, we used several available online databases (UCSC, TGCA, GO/KEGG, and GEO, among others) to perform analyses of expression, prognosis, and immune infiltration to evaluate the clinical value of SLC35A2 for CRC, identify the expression of SLC35A2 in clinical samples and cell lines of CRC patients and investigate its potential origin.